Copyright
©The Author(s) 2024.
World J Gastroenterol. Oct 28, 2024; 30(40): 4339-4353
Published online Oct 28, 2024. doi: 10.3748/wjg.v30.i40.4339
Published online Oct 28, 2024. doi: 10.3748/wjg.v30.i40.4339
Figure 3 Overview of regenerative therapies for diabetes treatment.
Cas9: CRISPR-associated protein 9; CRISPR: Clustered regularly interspaced short palindromic repeats; EGF: Epidermal growth factor; hESCs: Human embryonic stem cells; GLP-1: Glucagon-like peptide-1; iPSCs: Induced pluripotent stem cells; MSCs: Mesenchymal stem cells; TALENs: Transcription activator-like effector nucleases; ZFNs: Zinc finger nucleases.
- Citation: Abdalla MMI. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges. World J Gastroenterol 2024; 30(40): 4339-4353
- URL: https://www.wjgnet.com/1007-9327/full/v30/i40/4339.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i40.4339